Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Free Cash Flow (2022 - 2026)

Indivior Pharmaceuticals has reported Free Cash Flow over the past 5 years, most recently at -$29.0 million for Q1 2026.

  • For Q1 2026, Free Cash Flow fell 141.43% year-over-year to -$29.0 million; the TTM value through Mar 2026 reached -$192.0 million, down 265.52%, while the annual FY2025 figure was -$93.0 million, 1428.57% down from the prior year.
  • Free Cash Flow for Q1 2026 was -$29.0 million at Indivior Pharmaceuticals, up from -$245.0 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at $141.0 million in Q2 2025 and troughed at -$310.0 million in Q4 2023.
  • A 5-year average of -$28.7 million and a median of -$9.0 million in 2022 define the central range for Free Cash Flow.
  • On a YoY basis, Free Cash Flow climbed as much as 1200.0% in 2023 and fell as far as 3344.44% in 2023.
  • Year by year, Free Cash Flow stood at -$9.0 million in 2022, then plummeted by 3344.44% to -$310.0 million in 2023, then surged by 89.35% to -$33.0 million in 2024, then plummeted by 642.42% to -$245.0 million in 2025, then soared by 88.16% to -$29.0 million in 2026.
  • Business Quant data shows Free Cash Flow for INDV at -$29.0 million in Q1 2026, -$245.0 million in Q4 2025, and -$59.0 million in Q3 2025.